Notably, as the observed differences related to disease progression and Parkinsonism were biologically rational (inverse effects of pro-inflammatory RANTES and MCP-1 and anti-inflammatory IL-10), the results are likely to suggest biological pathways rather than coincidental type 1 errors. The gene discussed is CCL2; the disease is Parkinson disease.